44 related articles for article (PubMed ID: 23044892)
1. A novel dose-adjustment protocol for interrupted subcutaneous immunotherapy for allergic rhinitis.
Feng X; Liu J
Immunotherapy; 2023 Oct; 15(14):1171-1181. PubMed ID: 37585664
[TBL] [Abstract][Full Text] [Related]
2. A novel and well tolerated mite allergoid subcutaneous immunotherapy: evidence of clinical and immunologic efficacy.
Roger A; Depreux N; Jurgens Y; Heath MD; Garcia G; Skinner MA
Immun Inflamm Dis; 2014 Aug; 2(2):92-8. PubMed ID: 25400929
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy and safety evaluation of Dermatophagoides farinae drops in the treatment of allergic rhinitis with epistaxis.
Pei J; Ding Z; Cai L; Yang H; Tao Y; Huang C
Eur Ann Allergy Clin Immunol; 2024 May; ():. PubMed ID: 38813925
[No Abstract] [Full Text] [Related]
4. Safety, tolerability and efficacy of sublingual allergoid immunotherapy with three different shortened up-dosing administration schedules.
Passali D; Mösges R; Passali GC; Passali FM; Ayoko G; Bellussi L
Acta Otorhinolaryngol Ital; 2010 Jun; 30(3):131-7. PubMed ID: 20948588
[TBL] [Abstract][Full Text] [Related]
5. Study on Effects of Sublingual Immunotherapy in Allergic Rhinitis Patients.
Patel K; Gupta N; Prajapati BJ; Prajapati A; Sharma S; Rathava D
Indian J Otolaryngol Head Neck Surg; 2023 Apr; 75(Suppl 1):804-808. PubMed ID: 37206799
[TBL] [Abstract][Full Text] [Related]
6. A modified schedule of multiple aeroallergen ultra-rush immunotherapy in perennial allergic rhinitis: safety, efficacy, and T lymphocyte cell population studies.
Ariaee N; Fouladvand A; Mohammadi M; Farid-Hosseini R; Nikpoor AR; Khoshkhui M; Tavakkol-Afshari J; Jabbari-Azad F
Allergol Immunopathol (Madr); 2024; 52(3):65-72. PubMed ID: 38721957
[TBL] [Abstract][Full Text] [Related]
7. Environmental assessment and exposure control of dust mites: a practice parameter.
Portnoy J; Miller JD; Williams PB; Chew GL; Miller JD; Zaitoun F; Phipatanakul W; Kennedy K; Barnes C; Grimes C; Larenas-Linnemann D; Sublett J; Bernstein D; Blessing-Moore J; Khan D; Lang D; Nicklas R; Oppenheimer J; Randolph C; Schuller D; Spector S; Tilles SA; Wallace D; ;
Ann Allergy Asthma Immunol; 2013 Dec; 111(6):465-507. PubMed ID: 24267359
[No Abstract] [Full Text] [Related]
8. Efficacy of long-term sublingual-oral immunotherapy in allergic rhinitis.
Cingi C; Aynaci S; Cakli H; Cingi E; Ozüdogru E; Keçik C; Altin F; Bal C
Acta Otorhinolaryngol Ital; 2005 Aug; 25(4):214-9. PubMed ID: 16482978
[TBL] [Abstract][Full Text] [Related]
9. Loss of Olfactory Function-Early Indicator for Covid-19, Other Viral Infections and Neurodegenerative Disorders.
Rebholz H; Braun RJ; Ladage D; Knoll W; Kleber C; Hassel AW
Front Neurol; 2020; 11():569333. PubMed ID: 33193009
[TBL] [Abstract][Full Text] [Related]
10. Three-Year Follow-up Results of Sublingual Immunotherapy in Patients With Allergic Rhinitis Sensitized to House Dust Mites.
Kim SH; Mun SJ; Han DH; Kim JW; Kim DY; Rhee CS
Allergy Asthma Immunol Res; 2015 Mar; 7(2):118-23. PubMed ID: 25729618
[TBL] [Abstract][Full Text] [Related]
11. Current specific immunotherapy for allergic rhinitis: perspectives from otorhinolaryngologists.
Rhee CS
Allergy Asthma Immunol Res; 2014 Jul; 6(4):273-5. PubMed ID: 24991449
[No Abstract] [Full Text] [Related]
12. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy and safety of sublingual immunotherapy with house dust mite extract in poly allergen sensitized children with allergic rhinitis].
Zhou L; Wang J; Chen Y; Luo R; Tao J; Nie M; Liu B; Li Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 26(20):913-6. PubMed ID: 23272490
[TBL] [Abstract][Full Text] [Related]
14. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
Calderon MA; Casale TB; Nelson HS; Demoly P
J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
[TBL] [Abstract][Full Text] [Related]
15. SQ house dust mite (HDM) SLIT-tablet provides clinical improvement in HDM-induced allergic rhinitis.
Klimek L; Mosbech H; Zieglmayer P; Rehm D; Stage BS; Demoly P
Expert Rev Clin Immunol; 2016; 12(4):369-77. PubMed ID: 26788764
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of a once-daily sublingual immunotherapy without escalation regimen in house dust mite-induced allergic rhinitis.
Mun SJ; Shin JM; Han DH; Kim JW; Kim DY; Lee CH; Min YG; Rhee CS
Int Forum Allergy Rhinol; 2013 Mar; 3(3):177-83. PubMed ID: 23044892
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis.
Bergmann KC; Demoly P; Worm M; Fokkens WJ; Carrillo T; Tabar AI; Nguyen H; Montagut A; Zeldin RK
J Allergy Clin Immunol; 2014 Jun; 133(6):1608-14.e6. PubMed ID: 24388010
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
